Search

Displaying results 3591 - 3600 of 10000 in total
  1. Drug

    Fenoprofen

    go.drugbank.com/drugs/DB00573
    Approved

    An anti-inflammatory analgesic and antipyretic highly bound to plasma proteins. It is pharmacologically similar to aspirin, but causes less gastrointestinal bleeding.

  2. Drug

    Bucrylate

    go.drugbank.com/drugs/DB19727
    Experimental

    Bucrylate has a monoisotopic molecular weight of 153.08 Da.

    Categories: Compounds used in a research, industrial, or household setting
  3. Drug

    Glucarpidase

    go.drugbank.com/drugs/DB08898
    ApprovedInvestigational

    This can lead to delayed renal clearance of methotrexate and elevated drug plasma levels, increasing the risk of methotrexate toxicity. … [A7476,A7477] After the discovery of certain bacteria with the capacity to inactivate folate analogs such as methotrexate, carboxypeptidase G was identified and Carboxypeptidase G1 was first isolated

  4. Drug

    Octenidine

    go.drugbank.com/drugs/DB12624
    Investigational

    Octenidine is under investigation in clinical trial NCT02697162 (Antiseptic-coated Intermittent Urinary Catheter).

    Mixtures: Linola sept 1 mg/g + 10 mg/g Wund-Gel, Linola sept 1 mg/g + 20 mg/g Wund-Spray zur Anwendung auf der Haut, LösungProducts: Octeangin antisept 2,6 mg Pastillen, Octenimed 1 mg/ml Lösung zur Anwendung in der Mundhöhle
  5. Drug

    Insulin icodec

    go.drugbank.com/drugs/DB16693
    ApprovedInvestigational

    [L50758,A263818] Insulin icodec was approved by Health Canada in March 2024 for the treatment of adult patients with type 1 or 2 diabetes mellitus,[L50758] and was subsequently approved by the EMA in … It is a re-engineered version of the ultra long-acting oral basal insulin OI338, with several modifications introduced to significantly extend the half-life.

  6. Drug

    Ritobegron

    go.drugbank.com/drugs/DB12080
    Investigational

    Ritobegron is under investigation in clinical trial NCT02256735 (Study to Investigate the Effect of KUC 7483 CL on the QT/QTc Interval of the ECG in Comparison to Placebo and Moxifloxacin in Healthy Male

    Categories: Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
  7. Drug

    Naftifine

    go.drugbank.com/drugs/DB00735
    Approved

    Naftifine is a synthetic, broad spectrum, antifungal agent and allylamine derivative for the topical treatment of tinea pedis, tinea cruris, and tinea corporis caused by the organisms Trichophyton rubrum

    Products: Naftin, Naftin Gel 1%
  8. Drug

    Lysozyme

    go.drugbank.com/drugs/DB13260
    Investigational

    Mixtures: LYSOBACT 20 MG/10 MG PASTİL, 30 ADETProducts: NEUFLO TABLET 90 mg, LEFTOSE TABLETS (30 MG)
  9. Drug

    CGP 4832

    go.drugbank.com/drugs/DB04220
    Experimental

    Categories: Heterocyclic Compounds with 4 or More Rings
  10. Drug

    Trehalose-6-Phosphate

    go.drugbank.com/drugs/DB02430
    Experimental

    Categories: Compounds used in a research, industrial, or household setting